Supercharged CAR-T cells take on hard-to-treat lymphoma in early trial
Disease control
Recruiting now
This early-phase trial tests a new type of CAR-T cell therapy (Meta10-19) for adults with diffuse large B-cell lymphoma that has come back or not responded to prior treatment. The therapy adds a metabolic boost to help the immune cells work better against the cancer. The study ai…
Phase: EARLY_PHASE1 • Sponsor: He Huang • Aim: Disease control
Last updated May 02, 2026 17:13 UTC